Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRTCNASDAQ:ISRGNYSE:PATH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRTCiRhythm Technologies$150.95+3.6%$132.19$55.92▼$151.01$4.65B1.4480,243 shs472,443 shsISRGIntuitive Surgical$515.09+1.1%$528.53$413.82▼$616.00$182.56B1.671.67 million shs1.22 million shsPATHUiPath$12.24+0.5%$12.22$9.38▼$15.93$6.52B1.0610.41 million shs6.59 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRTCiRhythm Technologies+3.57%+4.24%+5.79%+41.60%+46.52%ISRGIntuitive Surgical+1.12%-0.76%-4.53%-0.91%+19.08%PATHUiPath+0.45%-1.91%-1.21%+7.94%+2.34%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIRTCiRhythm Technologies1.409 of 5 stars2.53.00.00.02.70.00.6ISRGIntuitive Surgical4.8289 of 5 stars3.45.00.04.03.62.51.9PATHUiPath2.716 of 5 stars3.02.00.00.02.44.20.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRTCiRhythm Technologies 2.90Moderate Buy$138.60-8.18% DownsideISRGIntuitive Surgical 2.70Moderate Buy$588.9514.34% UpsidePATHUiPath 2.00Hold$13.8313.02% UpsideCurrent Analyst Ratings BreakdownLatest ISRG, IRTC, and PATH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025IRTCiRhythm TechnologiesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $160.006/9/2025ISRGIntuitive SurgicalDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeHold ➝ Sell$515.00 ➝ $440.006/9/2025PATHUiPathDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold6/5/2025ISRGIntuitive SurgicalErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy6/2/2025PATHUiPathMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$12.00 ➝ $15.006/2/2025PATHUiPathCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$14.00 ➝ $16.005/30/2025PATHUiPathWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight5/30/2025PATHUiPathBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight5/30/2025PATHUiPathEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$11.00 ➝ $15.005/30/2025PATHUiPathBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$11.50 ➝ $15.505/30/2025PATHUiPathTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$12.00 ➝ $13.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRTCiRhythm Technologies$591.84M8.14N/AN/A$2.90 per share52.05ISRGIntuitive Surgical$8.71B21.18$8.08 per share63.76$46.41 per share11.10PATHUiPath$1.43B4.58$0.03 per share401.54$3.33 per share3.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRTCiRhythm Technologies-$113.29M-$3.14N/AN/AN/A-15.90%-101.04%-9.55%7/30/2025 (Estimated)ISRGIntuitive Surgical$2.32B$6.8275.5367.515.4028.41%14.43%12.81%7/17/2025 (Estimated)PATHUiPath-$73.69M-$0.12N/AN/A15.96-4.65%-3.05%-1.99%9/4/2025 (Estimated)Latest ISRG, IRTC, and PATH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/17/2025Q2 2025ISRGIntuitive Surgical$1.92N/AN/AN/A$2.35 billionN/A5/29/2025Q1 2026PATHUiPath$0.10$0.11+$0.01-$0.04$332.17 million$356.62 million5/1/2025Q1 2025IRTCiRhythm Technologies-$0.89-$0.95-$0.06-$0.97$153.39 million$158.68 million4/22/2025Q1 2025ISRGIntuitive Surgical$1.71$1.81+$0.10$1.92$2.19 billion$2.25 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIRTCiRhythm TechnologiesN/AN/AN/AN/AN/AISRGIntuitive SurgicalN/AN/AN/AN/AN/APATHUiPathN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRTCiRhythm Technologies7.475.715.58ISRGIntuitive SurgicalN/A4.983.97PATHUiPathN/A2.952.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRTCiRhythm TechnologiesN/AISRGIntuitive Surgical83.64%PATHUiPath62.50%Insider OwnershipCompanyInsider OwnershipIRTCiRhythm Technologies0.68%ISRGIntuitive Surgical0.70%PATHUiPath23.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRTCiRhythm Technologies2,00031.92 million31.71 millionOptionableISRGIntuitive Surgical15,638358.42 million355.91 millionOptionablePATHUiPath4,010535.04 million410.96 millionOptionableISRG, IRTC, and PATH HeadlinesRecent News About These CompaniesInsider Selling: UiPath, Inc. (NYSE:PATH) CEO Sells 45,000 Shares of StockJune 24 at 4:38 AM | insidertrades.comUiPath, Inc. (NYSE:PATH) CEO Sells $544,500.00 in StockJune 23 at 5:47 PM | marketbeat.comPalantir vs. UiPath: Which AI-First Software Stock Deserves Your Bet?June 23 at 1:55 PM | zacks.com5 Mid-Cap Stocks to Buy on Solid Long-Term Earnings Growth PotentialJune 23 at 8:46 AM | zacks.comTop 5 Budget-Friendly AI Stocks to Invest in TodayJune 22 at 12:11 AM | msn.comUiPath Showcases Next-Generation Enterprise-Grade Platform at Australian Agentic Automation SummitJune 20, 2025 | itwire.comBank NXT, UiPath team up to reinforce Egypt’s banking digital transformationJune 19, 2025 | zawya.comBank NXT partners with UiPath and BMB EgyptJune 18, 2025 | zawya.comAssenagon Asset Management S.A. Reduces Holdings in UiPath Inc. (NYSE:PATH)June 17, 2025 | marketbeat.comFort Washington Investment Advisors Inc. OH Purchases 42,645 Shares of UiPath Inc. (NYSE:PATH)June 14, 2025 | marketbeat.comWhat is Scotiabank's Forecast for UiPath FY2026 Earnings?June 14, 2025 | americanbankingnews.comUiPath Stock Appears Undervalued Based on Forward P/S RatioJune 13, 2025 | zacks.comUiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on ItJune 13, 2025 | zacks.comStanley Laman Group Ltd. Buys 388,971 Shares of UiPath Inc. (NYSE:PATH)June 13, 2025 | marketbeat.comBuy 5 AI-Focused Mid-Cap Internet Software Stocks for a Solid PortfolioJune 13, 2025 | zacks.comUiPath Inc. (NYSE:PATH) Shares Sold by Avanza Fonder ABJune 13, 2025 | marketbeat.comScotiabank Analysts Increase Earnings Estimates for UiPathJune 12, 2025 | marketbeat.comUiPath Inc. (PATH) Presents at Mizuho Technology Conference 2025 TranscriptJune 11, 2025 | seekingalpha.comUiPath strengthens leadership team with the appointment of Area Vice President UK & IrelandJune 11, 2025 | tmcnet.comResearch Analysts Issue Forecasts for UiPath Q2 EarningsJune 11, 2025 | marketbeat.comUiPath Inc. (NYSE:PATH) Shares Bought by Pallas Capital Advisors LLCJune 11, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingIntuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?By Leo Miller | June 19, 2025View Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?ISRG, IRTC, and PATH Company DescriptionsiRhythm Technologies NASDAQ:IRTC$150.95 +5.21 (+3.57%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$151.26 +0.31 (+0.21%) As of 06/23/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Intuitive Surgical NASDAQ:ISRG$515.09 +5.73 (+1.12%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$515.98 +0.88 (+0.17%) As of 06:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.UiPath NYSE:PATH$12.24 +0.06 (+0.49%) Closing price 06/23/2025 03:59 PM EasternExtended Trading$12.44 +0.20 (+1.59%) As of 06:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
